Neurobiological modulation with REAC technology: enhancing pain, depression, anxiety, stress, and quality of life in post-polio syndrome subjects

Abstract

Post-polio syndrome (PPS) brings new challenges for polio survivors, including muscle decline, pain, depression, and diminished quality of life. This study explored the potential of REAC neuromodulatory treatments to ease pain, improve mood, and enhance quality of life in PPS patients. 17 individuals with PPS (average age 54.8) received three REAC treatments: Neuro Postural Optimization, Neuro Psycho Physical Optimization, and Neuro Psycho Physical Optimization-Cervico Brachial. Pain, depression, anxiety, stress, and quality of life were assessed before and after using established scales. REAC treatments significantly reduced pain across various dimensions, along with depression, anxiety, and stress levels. Additionally, patients reported improved physical and psychological quality of life. This study suggests REAC neuromodulatory treatments as a promising non-invasive option to improve pain, emotional well-being, and quality of life in individuals with PPS.

Keywords: Anxiety; Depression; Pain; Post-polio syndrome; Quality of life; REAC technology; Stress.

Figure 1

The figure displays the means of the scores for the sensory, affective, evaluative and miscellaneous dimensions of the McGill Pain Test in the T0 (N = 17), T2 (N = 17), T3 (N = 17), and T4 (N = 17) conditions.

Figure 2

The figure displays the means of depression, anxiety and stress scores from the DASS-21 test in the T0 (N = 16), (2) T2 (N = 16), T3 (N = 16), and T4 (N = 16) conditions.

Figure 3

The figure shows the mean scores of the physical, phycological, social and environmental dimensions of the WHOQoL-bref test in the following conditions: T0 (N = 15), T2 (N = 15), T3 (N = 15), and T4 (N = 15).

Figure 4

Study flowchart and phases.